Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients

BACKGROUND: Ferumoxytol was first approved for clinical use in 2009 solely based on data from trial comparisons with oral iron on biochemical anemia efficacy end points. To compare the rates of important patient outcomes (infection, cardiovascular events and death) between facilities predominantly u...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nephrol Dial Transplant
Auteurs principaux: Airy, Medha, Mandayam, Sreedhar, Mitani, Aya A., Chang, Tara I., Ding, Victoria Y., Brookhart, M. Alan, Goldstein, Benjamin A., Winkelmayer, Wolfgang C.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Clinical Science
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829057/
https://ncbi.nlm.nih.gov/pubmed/26311216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv305
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires